Curcumin seems to be a promising and safe medication for maintaining remission in patients with quiescent UC. Further studies on curcumin should strengthen our findings. Read more »
Curcumin inhibits microvascular endothelial cell angiogenesis through inhibition of COX-2 expression and PGE2 production, suggesting that this natural product possesses anti- angiogenic properties, which warrants further investigation as adjuvant treatment of IBD and cancer. Read more »
In this study, there was no significant difference in stool sulfide between control and colitic patients. Disease extent or activity did not significantly influence stool sulfide. These results do not support a primary etiologic role for luminal sulfide in ulcerative colitis. Read more »
